Patents Assigned to TauDerma SA
  • Patent number: 10813962
    Abstract: An extract obtained from Saxifraga sp., Astrantia major, or a combination thereof and a method of treating or relieving an inflammatory-skin related condition in a subject is provided. The method comprises administering or applying a composition comprising an effective amount of an extract from Saxifraga sp., Astrantia major or a combination thereof, and a carrier, wherein the effective amount of the extract inhibits tumor necrosis factor alpha and Interleukine-1beta activity. The inflammation may be inflammation of the skin and the composition may be a skin preparation for external use.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: October 27, 2020
    Assignee: TauDerma SA
    Inventors: Vincent Mutel, Xavier Simonnet, Bruno Schnyder